MIGAUSKY GEORGE V 4
4 · REGENXBIO Inc. · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
REGENXBIO Director George V. Migausky Receives Awards
What Happened
- George V. Migausky, a director of REGENXBIO, was granted equity awards on May 29, 2026: 9,807 restricted stock units (RSUs) and a derivative award (stock option) for 46,600 shares. Both awards were granted at $0.00 (no cash exchanged). Total potential shares = 56,407. These are awards (not open‑market purchases or sales).
Key Details
- Transaction date: May 29, 2026; filing date: June 2, 2026 (filed within the required two business days).
- Price: $0.00 for both awards (code A — grant/award).
- Vesting: Per footnotes, 100% of the RSUs and the option vest on May 29, 2027, subject to the recipient’s continued service.
- Shares owned after transaction: Not specified in this Form 4 filing.
- Footnotes: F1 = RSU vests 100% on 5/29/2027; F2 = option vests on 5/29/2027 (continuous service condition).
Context
- RSUs convert to shares upon vesting; the option gives the right to purchase shares if and when vested and exercised. Neither award represents immediately tradable shares today and no cash was paid. Such time‑based grants are common for directors and reflect compensation, not an open‑market investment decision.
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
MIGAUSKY GEORGE V
Director
Transactions
- Award
Common Stock
[F1]2026-05-29+9,807→ 28,861 total - Award
Stock Options (Right to Buy)
[F2]2026-05-29+46,600→ 46,600 totalExercise: $7.01From: 2027-05-29Exp: 2036-05-29→ Common Stock (46,600 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer.
- [F2]The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer.
Signature
/s/ Patrick J. Christmas as attorney-in-fact|2026-06-02